Clinical Trial Update: Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions [Phase 1]

View source ↗

Summary

A Phase 1 relative bioavailability study comparing Ribavirin 200 mg capsules with Rebetol 200 mg capsules in females under non-fasting conditions for Chronic He…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Rebetol (ribavirin)
• Ribavirin (ribavirin)

Snippet

Sponsor: Sandoz | Conditions: Chronic Hepatitis C | Phase 1 | Status: COMPLETED